Simvastatin has anti-tumorigenic effects in endometrial cancer via reversal of obesity-driven upregulation of lipid biosynthesis

被引：0
|
作者：
West, L. [1 ]
Clark, L. H. [1 ]
Pierce, S. R. [1 ]
Yin, Y. [1 ]
Fang, Z. [1 ]
Lee, D. [2 ]
Zhou, C. [1 ]
Bae-Jump, V. L. [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
[2] Omic Insight LCC, Durham, NC USA
来源：
GYNECOLOGIC ONCOLOGY | 2018年 / 149卷
关键词：
D O I：
10.1016/j.ygyno.2018.04.040
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
29
引用
收藏
页码：16 / 16
页数：1
相关论文
共 37 条
  • [1] ONC201 has anti-tumorigenic effects in obesity-driven endometrial cancer
    Tucker, K.
    Staley, A.
    Pierce, S. R.
    Fan, Y.
    Yin, Y.
    Sun, W.
    Zhao, X.
    Zhang, Y.
    Lee, D.
    Prabhu, V.
    Zhou, C.
    Bae-Jump, V. L.
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 : 49 - 49
  • [2] ONC201 has anti-tumorigenic activity in obesity-driven epithelial ovarian cancer
    Hawkins, G. M.
    Fan, Y.
    Fang, Z.
    Huang, Y.
    Sun, W.
    Paraghamian, S. E.
    Yin, Y.
    Prabhu, V. V.
    Allen, J. E.
    Zhou, C.
    Bae-Jump, V. L.
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 159 : 28 - 29
  • [3] From Fat to Fit: Diet switch reverses obesity-driven upregulation of lipid biosynthesis in endometrial cancer
    West, L.
    Clark, L. H.
    Pierce, S. R.
    Yin, Y.
    Zhou, C.
    Bae-Jump, V. L.
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 149 (03) : 621 - 622
  • [4] From fat to fit: Diet switch reverses obesity-driven upregulation of lipid biosynthesis in endometrial cancer
    West, L.
    Pierce, S. R.
    Clark, L. H.
    Yin, Y.
    Fang, Z.
    Lee, D.
    Zhou, C.
    Bae-Jump, V. L.
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 149 : 173 - 173
  • [5] Sulindac, a COX1/COX2 inhibitor, exhibits anti-tumorigenic effects in obesity-driven models of endometrioid endometrial cancer
    John, Catherine
    Zhao, Ziyi
    Shen, Xiaochang
    Deng, Boer
    Strauss, Isabella
    Zhou, Chunxiao
    Sherman, Mark
    Hursting, Stephen
    Bae-Jump, Victoria
    [J]. GYNECOLOGIC ONCOLOGY, 2023, 176 : S309 - S309
  • [6] Reversal of obesity-driven aggressiveness of endometrial cancer by metformin
    Sullivan, S. A.
    Tran, A. M.
    Clark, L. H.
    Bateman, N. W.
    Hood, B. L.
    Conrads, T. P.
    Lee, D.
    Zhou, C.
    Makowski, L.
    Bae-Jump, V. L.
    [J]. GYNECOLOGIC ONCOLOGY, 2017, 145 : 21 - 22
  • [7] Reversal of obesity-driven aggressiveness of endometrial cancer by metformin
    Guo, Hui
    Kong, Weimin
    Zhang, Lu
    Han, Jianjun
    Clark, Leslie H.
    Yin, Yajie
    Fang, Ziwei
    Sun, Wenchuan
    Wang, Jiandong
    Gilliam, Timothy P.
    Lee, Douglas
    Makowski, Liza
    Zhou, Chunxiao
    Bae-Jump, Victoria L.
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (10): : 2170 - 2193
  • [8] Maresin-1, a specialized-pro-resolving mediator of inflammation, demonstrates anti-tumorigenic activity in obesity-driven endometrial cancer (EC)
    John, Catherine
    Deng, Boer
    Shen, Xiaochang
    Zhao, Ziyi
    Sherman, Mark
    Milne, Ginger
    Hursting, Stephen
    Lee, Douglas
    Zhou, Chunxiao
    Bae-Jump, Victoria
    [J]. GYNECOLOGIC ONCOLOGY, 2023, 173 : S12 - S12
  • [9] The dopamine receptor D2 antagonist ONC201 has anti-tumorigenic activity in obesity-driven epithelial ovarian cancer
    Staley, Allison
    Tucker, Katherine
    Fang, Ziwei
    Fan, Yali
    Sun, Wenchuan
    Yin, Yajie
    Zhang, Yingao
    Prabhu, Varun
    Zhou, Chunxiao
    Bae-Jump, Victoria
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [10] Docosahexaenoic acid demonstrates anti-tumorigenic effects in endometrial cancer
    O'Donnell, Jillian A.
    Buckingham, Lindsey K.
    Pierce, Stuart R.
    West, Lindsay
    Yin, Yiajie
    Sun, Wenchuan
    Fang, Ziwei
    Lee, Douglas
    Zhou, Chunxiao
    Bae-Jump, Victoria L.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (02) : 395 - 396
1234